837P Phase II study of anbal-cel, novel anti-CD19 CAR-T therapy with dual silencing of PD-1 and TIGIT: Drug characteristics, immunologic and genetic biomarkers associated with treatment outcome and toxicities
| Autor: | Kim, W.S., Kim, S.J., Yoon, D.H., Eom, H-S., Yang, D.H., Yoon, S-S., Yoon, S.E., Cho, H., Lee, E-Y., Lee, H.W., Jung, J-H., Song, G-Y., Koh, Y., Choi, S-H., Park, Y., Kim, J.R. |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S548-S548 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|